Zhejiang Fulai New Material Co (605488) Fair Value & Analysis
Basic Materials · CN · Market cap 10.3B CNY
Analysis
Zhejiang Fulai New Material Co (605488) currently trades at ¥30.41, while our model-based Fair Value estimate is ¥4.35 — implying the stock looks roughly 85.7% overvalued today. We read business quality at 92/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Zhejiang Fulai New Material Co.,Ltd., together with its subsidiaries, researches, develops, produces, and sells functional coating composite products in China and internationally. It operates through Advertising Inkjet Printing Materials; Label Identification Printed Materials; Electronic Grade Functional Materials; Functional Basement Membrane Material; and Other segments. The company offers advertising inkjet printing materials comprising adhesive/PP, car body sticker, cold lamination and light film, display rack, and water/white transparent series; labels and logo printing materials consisting of inkjet, digital, tag, and special series, as well as basic membrane; and electronic grade functional materials, such as ultra-thin tape, PET double-sided tape, grid tape, silicone protective film, acrylic protective film, PU protective film, and release film series. It also provides home decoration materials, including home protection, privacy protection, home decoration, and digital hot…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.